Pfizer Seeks Opportunities In China's Rural Market
This article was originally published in PharmAsia News
Executive Summary
Pfizer is seeking opportunities in China's healthcare reform by entering small towns and rural regions. Reflecting this commitment, Pfizer CEO Jeff Kindler recently visited grassroots medical institutions in Luzhou, a small town in Sichuan (PharmAsia News, July 30, 2008). Pfizer and Tsinghua University are collaborating on a long-distance medical training project to train physicians from outlying areas; the drug giant is also making available its anti-tumor drug Sutent to local patients with serious cancers. Pfizer hopes to keep in touch remotely with rural doctors through the exercise even if its expensive drug is not prescribed. Instead of limiting itself to the high-end market, the company aims to expand its coverage from the current 170 cities to 600 over several years. (Click here for more - Chinese Language)
|
Pfizer is seeking opportunities in China's healthcare reform by entering small towns and rural regions. Reflecting this commitment, Pfizer CEO Jeff Kindler recently visited grassroots medical institutions in Luzhou, a small town in Sichuan (Also see "As Merger With Wyeth Hangs In The Balance Of Beijing's Hands, Pfizer CEO Tours China To Launch Scholarly Partnerships" - Scrip, 30 Jul, 2009.). Pfizer and Tsinghua University are collaborating on a long-distance medical training project to train physicians from outlying areas; the drug giant is also making available its anti-tumor drug Sutent to local patients with serious cancers. Pfizer hopes to keep in touch remotely with rural doctors through the exercise even if its expensive drug is not prescribed. Instead of limiting itself to the high-end market, the company aims to expand its coverage from the current 170 cities to 600 over several years. (Click here for more - Chinese Language) " CEO Regards China A Crucial Market" - caijing.com.cn (8/12/09) |